New! Sign up for our free email newsletter.
Science News
from research organizations

Resistin Arrest: New Approach Shows Human Resistin Contributes To Insulin Resistance

Date:
February 3, 2009
Source:
Journal of Clinical Investigation
Summary:
Individuals who are obese have an increased risk of developing type 2 diabetes, in part because they often become resistant to the effects of the hormone insulin. Resistin is a soluble factor produced by fat cells (adipocytes) that is linked to the development of insulin resistance in mice. However, studies have thus far failed to determine such a clear association in humans. But now, researchers have determined that human resistin contributes to the development of insulin resistance in mice.
Share:
FULL STORY

Individuals who are obese have an increased risk of developing type 2 diabetes, in part because they often become resistant to the effects of the hormone insulin. Resistin is a soluble factor produced by fat cells (adipocytes) that is linked to the development of insulin resistance in mice. However, studies have thus far failed to determine such a clear association in humans.

But now, Mitchell Lazar and colleagues, at the University of Pennsylvania, Philadelphia, have determined that human resistin contributes to the development of insulin resistance in mice.

The research appears online, Feb. 2nd, 2009, in the Journal of Clinical Investigation.

One factor that has complicated studies attempting to determine the role of resistin in the development of insulin resistance in humans, is that resistin is produced mainly by immune cells known as macrophages in humans, whereas it is produced by adipocytes in mice.

To overcome this issue, the authors generated mice lacking mouse resistin and expressing human resistin in macrophages. When these mice were fed a high-fat diet, they developed inflammation of the fat tissue, which led to altered levels of fats in the blood and, ultimately, to insulin resistance.

It is hoped that future studies using these mice will help determine the therapeutic potential of modulating levels of human resistin.


Story Source:

Materials provided by Journal of Clinical Investigation. Note: Content may be edited for style and length.


Journal Reference:

  1. Mohammed Qatanani, Nava R. Szwergold, David R. Greaves, Rexford S. Ahima, Mitchell A. Lazar. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J. Clin. Invest., 2009; DOI: 10.1172/JCI37273

Cite This Page:

Journal of Clinical Investigation. "Resistin Arrest: New Approach Shows Human Resistin Contributes To Insulin Resistance." ScienceDaily. ScienceDaily, 3 February 2009. <www.sciencedaily.com/releases/2009/02/090202174701.htm>.
Journal of Clinical Investigation. (2009, February 3). Resistin Arrest: New Approach Shows Human Resistin Contributes To Insulin Resistance. ScienceDaily. Retrieved April 26, 2024 from www.sciencedaily.com/releases/2009/02/090202174701.htm
Journal of Clinical Investigation. "Resistin Arrest: New Approach Shows Human Resistin Contributes To Insulin Resistance." ScienceDaily. www.sciencedaily.com/releases/2009/02/090202174701.htm (accessed April 26, 2024).

Explore More

from ScienceDaily

RELATED STORIES